25.02.2019 • NewsbiologicsCatalentDrug Delivery

Catalent Appoints Kay Schmidt as Senior Vice President of Technical Operations

Kay Schmidt has been appointed as Catalents senior vice president, Technical...
Kay Schmidt has been appointed as Catalent's senior vice president, Technical Operations. Source: Catalent

Catalent appointed Kay Schmidt as senior vice president, Technical Operations. In this new role, Schmidt will report to Alessandro Maselli, who earlier this month was appointed as Catalent’s new president and chief operating officer.

Schmidt joined Catalent in 2009, holding several leadership roles in product development. Most recently, she headed Catalent’s global virtual Project Management Organization for new product introductions, in addition to her role as vice president, Product Development in the company’s Biologics and Specialty Drug Delivery business unit. Prior to joining Catalent, she held various positions at GE Healthcare. She has a bachelor’s degree from Carroll University, Wisconsin and a master’s degree from the University of Wisconsin-Whitewater.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read